Top

Reactions Weekly

Published in:

01-03-2024 | Acalabrutinib | Case report

CD19-Chimeric-Antigen-Receptor-T-cell-therapy-Takara-Bio

Immune effector cell-associated neurotoxicity syndrome

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Nie EH, et al. Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma. Journal of Neuropathology and Experimental Neurology 82 : 160-168, Feb 2023. Available from: URL: https://dx.doi.org/10.1093/jnen/nlac121

Title: CD19-Chimeric-Antigen-Receptor-T-cell-therapy-Takara-Bio
Immune effector cell-associated neurotoxicity syndrome
Publication date: 01-03-2024
Publisher: Springer International Publishing
Keywords: Acalabrutinib
Mantle Cell Lymphoma
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-54418-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CD19-Chimeric-Antigen-Receptor-T-cell-therapy-Takara-Bio

Immune effector cell-associated neurotoxicity syndrome

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Cyclophosphamide/furosemide/sodium-chloride

Prednisolone/steroids

Immune-globulin/oxcarbazepine

Multiple drugs

Nitric-oxide

Dupilumab